Current News

Contact | Print version | PDF version | Send article | RSS feed

Lab21 appoints new CEO

07 Nov 2007 - Lab21 has announced the appointment of Graham Mullis as its new CEO. Graham has held executive positions at FTSE and Nasdaq listed medical device companies including 1-800 Contacts Inc and Biocompatibles International PLC and pharmaceutical roles at Hoechst Roussel Ltd and R P Scherer Ltd. He has experience in successfully launching new businesses and technologies in healthcare markets, with IPO and extensive M&A experience at a variety of medical and pharmaceutical companies. Graham has an MBA from Warwick Business School and BSc in Biochemistry with Physiology from Southampton University.
 
Graham joins Lab21 from Optivue Ltd, a company formed to develop and license pharmaceutical & medical device applications in optical products, where he is a co-founder.